drugset / Trial / NCT01433575
A Pharmacokinetic Study of RO4917838 in Healthy Chinese Volunteers
RandomizedCrossoverOpen-label
Summary
This single-center, open-label, single dose, randomized, two-way cross-over study will evaluate the pharmacokinetics, safety and tolerability of RO4917838 in healthy Chinese volunteers. Subjects will be randomized to receive a single oral dose of either 10 mg or 20 mg RO4917838 and, after a washout period of at least 21 but no more than 35 days, will be re-dosed with the alternative treatment. Anticipated time on study is up to 70 days.
Timeline
- Start
- 2011-09
- Primary completion
- 2011-11
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | bitopertin | Small molecule | 10 mg | Oral |
| Subject | bitopertin | Small molecule | 20 mg | Oral |
Indications
No indication recorded.